Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001613377-17-000030

Options or other derivatives

  • CEO / President acquired 20,786 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Equels Thomas K. · CEO / President

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-07-31 Grant or award : show line 1 in the form Options to buy Common Stock +20,786 $0.30 $6,236 20,786 D
Loading xslF345X03/primary_doc.xml…